Stocks SBGI Financial statements
Financial statementsSinclair, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Sinclair, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 6,134 | 3,928 | 3,134 | 3,548 | 3,169 |
| Selling, general and administrative | 908 | 812 | 747 | 794 | 806 |
| General and administrative | 170 | 160 | 694 | 185 | 185 |
| Operating expenses | 6,039 | -52 | 3,465 | 2,997 | 2,996 |
| Operating income | 95 | 3,980 | -331 | 551 | 173 |
| Interest expense | 618 | 296 | 305 | 304 | 395 |
| Other non-operating income | -594 | -366 | -306 | -156 | -326 |
| Pre-tax income | -499 | 3,614 | -637 | 395 | -153 |
| Income tax | -173 | 913 | -358 | 76 | -54 |
| Net income | -414 | 2,652 | -291 | 310 | -112 |
| EBITDA | 686 | 4,301 | -60 | 801 | 422 |
| EPS, basic | -5.51 | 37.54 | -4.46 | 4.72 | -1.61 |
| EPS, diluted | -5.51 | 37.54 | -4.46 | 4.69 | -1.61 |
| Shares, basic (weighted) | 75.1 | 70.7 | 65.1 | 65.8 | 69.1 |
| Shares, diluted (weighted) | 75.1 | 70.7 | 65.1 | 66.1 | 69.1 |
Balance sheet
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 819 | 884 | 662 | 697 | 866 |
| Receivables | 612 | 616 | 637 | 687 | |
| Other current assets | 182 | 189 | 146 | 147 | |
| Total current assets | 1,683 | 1,475 | 1,485 | 1,700 | |
| Property, plant and equipment | 728 | 715 | 705 | 655 | |
| Lease right-of-use assets | 145 | 142 | 123 | 110 | |
| Goodwill | 2,088 | 2,088 | 2,082 | 2,082 | 2,085 |
| Intangible assets | 946 | 779 | 630 | 533 | |
| Other non-current assets | 964 | 742 | 710 | 717 | |
| Total assets | 6,704 | 6,085 | 5,885 | 5,949 | |
| Accounts payable | 397 | 913 | 416 | 496 | |
| Accrued liabilities | 397 | 913 | 416 | 496 | |
| Short-term debt | 38 | 36 | 38 | 25 | |
| Total current liabilities | 608 | 1,103 | 605 | 703 | |
| Long-term debt | 4,227 | 4,139 | 4,091 | 4,358 | |
| Lease liabilities | 154 | 152 | 130 | 112 | |
| Other non-current liabilities | 220 | 204 | 195 | 180 | |
| Total liabilities | 5,829 | 5,864 | 5,369 | 5,579 | |
| Total debt | 35 | 4,148 | 4,087 | 4,350 | |
| Paid-in capital | 624 | 517 | 570 | 613 | |
| Retained earnings | 122 | -234 | 10 | -171 | |
| Other comprehensive income | 1 | 1 | 2 | 0 | |
| Shareholders' equity | 748 | 285 | 583 | 443 | |
| Minority interests | -67 | -64 | -67 | -73 | |
| Total equity | -1,706 | 681 | 221 | 516 | 370 |
| Total liabilities and equity | 6,704 | 6,085 | 5,885 | 5,949 |
Cash flow statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | -326 | 2,701 | -279 | 319 | -99 |
| Depreciation and amortization | 591 | 321 | 271 | 250 | 249 |
| Stock-based compensation | 60 | 50 | 45 | 51 | 51 |
| Deferred income tax | -97 | 904 | -358 | 82 | -121 |
| Change in receivables | -187 | 20 | -8 | -28 | -47 |
| Change in payables | 113 | -14 | 512 | -495 | 43 |
| Cash from operations | 327 | 799 | 235 | 98 | 189 |
| Capital expenditures | -80 | -105 | -92 | -84 | -74 |
| Acquisitions | -10 | 0 | 0 | -29 | |
| Purchases of investments | -256 | -75 | -72 | -50 | -51 |
| Sales and maturities of investments | 26 | 99 | 206 | 203 | 30 |
| Cash from investing | -246 | -381 | 52 | 77 | -120 |
| Debt issued | 357 | 728 | 0 | 0 | 1,805 |
| Share buybacks | -61 | -120 | -153 | 0 | 0 |
| Dividends paid | -60 | -70 | -65 | -66 | -69 |
| Cash from financing | -524 | -353 | -509 | -140 | 100 |
| Net change in cash | -443 | 65 | -222 | 35 | 169 |
| Free cash flow | 247 | 694 | 143 | 14 | 115 |
| Interest paid | 583 | 387 | 294 | 296 | 324 |
| Income taxes paid | 16 | 18 | 4 | 3 | 45 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 6.6% | Operating income / revenue. |
| EBITDA margin | 14.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 0.6% | Pre-tax income / revenue. |
| Net margin | 1.6% | Net income / revenue. |
| FCF margin | 2.9% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 5.3% | Cash from operations / revenue. |
| Effective tax rate | -190.5% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 13.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | 4.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 26.0% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 1.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.3% | Capital expenditures / revenue. |
| D&A / revenue | 8.0% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -10.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -6.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -68.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -64.8% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -47.3% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -53.9% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -136.1% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -134.3% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | 92.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -38.2% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 721.4% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -45.1% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | -24.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -16.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 1.1% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -3.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 4.6% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.94x | Current assets / current liabilities. |
| Quick ratio | 1.75x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.85x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 10.6x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 73.6% | Total debt / total assets. |
| Liabilities / assets | 94.5% | Total liabilities / total assets. |
| Net debt | $3.43B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 7.21x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 0.64x | Operating income / interest expense. |
| Working capital | $674.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 38.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$1.70B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.59x | Revenue / average total assets. |
| Fixed asset turnover | 5.14x | Revenue / average property, plant and equipment. |
| Receivables turnover | 5.03x | Revenue / average receivables. |
| Days sales outstanding | 73 days | 365 x average receivables / revenue. |
| FCF conversion | 182.7% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 44.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.72 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $45.12 | Revenue / diluted weighted shares. |
| FCF per share | $1.32 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $2.37 | Cash from operations / diluted weighted shares. |
| Book value per share | $5.27 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$23.60 | Tangible book value / shares outstanding. |
| Cash per share | $8.37 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 136.5% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 74.7% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $924.2M | Share price x shares outstanding. |
| Enterprise value | $4.36B | Market cap + total debt - cash - short-term investments. |
| P/E | 17.8x | Market cap / net income. Only when net income is positive. |
| P/S | 0.28x | Market cap / revenue. |
| P/B | 2.43x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 9.73x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 5.40x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.34x | Enterprise value / revenue. |
| EV/EBIT | 20.3x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 9.15x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 45.9x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 10.3% | Free cash flow / market cap. |
| Earnings yield | 5.6% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 7.7% | Dividends paid over the period / market cap. |
| Shareholder yield | 7.7% | (Dividends paid + share buybacks) / market cap. |
What was Sinclair, Inc.'s revenue in fiscal 2025?
Sinclair, Inc. reported revenue of $3.17B for fiscal 2025, 10.7% lower than the year before.
Was Sinclair, Inc. profitable in fiscal 2025?
No. It reported a net loss of $112.0M.
How much free cash flow did Sinclair, Inc. generate in fiscal 2025?
Cash from operations of $189.0M minus capital expenditures of $74.0M left free cash flow of $115.0M.